1. Bayer Pharmaceuticals Corporation (7 from 70 patents)

2. Cara Therapeutics, Inc. (5 from 31 patents)

3. Abbott Laboratories Corporation (4 from 4,177 patents)

4. University of Pittsburgh (4 from 1,860 patents)

5. Bayer Healthcare LLC (4 from 780 patents)

6. Other (1 from 832,680 patents)

7. Bayer Intellectual Property Gmbh (1 from 721 patents)

8. Bayer Pharma Aktiengesellschaft (378 patents)

1. 11986509 - Oligosaccharide formulations of kappa opioid receptor agonists

2. 11684674 - Oral formulations of kappa opioid receptor agonists

3. 11033629 - Oral formulations of kappa opioid receptor agonists

4. 8835422 - Substituted imidazoheterocycle derivatives

5. 8431695 - Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases

6. 8143393 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

7. 8129379 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

8. 8013166 - Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

9. 7968576 - Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

10. 7960377 - Substituted pyridoxazines

11. 7759376 - Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity

12. 7423156 - Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

13. 7091228 - Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

14. 7071207 - Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity

15. 6960601 - Preparation and use of imidazole derivatives for treatment of obesity